HCT

Aduro Clean Technologies Provides Update on Joint Western University Research Project

Retrieved on: 
Thursday, April 4, 2024
ACT, Western University, Oil, Benchmarking, Recycling, Partnership, LDPE, Knowledge, Monomer, Research, Pyrolysis, PP, Mentorship, Behavior, Chemistry, Plastic, Chemical substance, HDPE, HCT

Over the duration of the project, the research program will employ a total of 19 highly skilled research members and engineers.

Key Points: 
  • Over the duration of the project, the research program will employ a total of 19 highly skilled research members and engineers.
  • Building on our commitment to nurturing talent, Aduro has already offered positions to outstanding graduates from the project, enabling them to continue their impactful work as full-time Aduro employees.
  • “We are happy to provide this update and report on the significant project progress to date.
  • The synergistic relationship we've cultivated with Western University, is not only advancing critical research but also fostering the next generation of scientific leaders to join our team,” stated Ofer Vicus, CEO of Aduro.

Aduro Clean Technologies Welcomes a Multinational Building Materials Company into its Customer Engagement Program

Retrieved on: 
Wednesday, March 27, 2024
ACT, Oil, Recycling, Polymer, Ventilation, Electronics, Cross, Client, Chemistry, Heart, CEP, HCT

LONDON, March 27, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is excited to announce the onboarding of a leading, multinational building materials company (“MBM Company” or the “Client”) to its Customer Engagement Program (CEP).

Key Points: 
  • LONDON, March 27, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is excited to announce the onboarding of a leading, multinational building materials company (“MBM Company” or the “Client”) to its Customer Engagement Program (CEP).
  • MBM Company, with extensive manufacturing operations across over 20 countries and a global distribution reach, generates multi-billion-dollar annual revenues.
  • The Client is recognized for its vast range of building materials and is dedicated to promoting sustainability through material circularity—emphasizing the recycling and reuse of materials across its product lines.
  • “Our dedication to providing customer-centric solutions is at the heart of what we do,” commented Ofer Vicus, CEO at Aduro.

Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results

Retrieved on: 
Monday, March 25, 2024
Research, SJD, IDMC, Conference call, Conference, Retinoblastoma, Telephone, Patient, Acquisition, Cancer, VCN, Insurance, Bank statement, GMP, Clinical trial, Safety, Sant Joan, Therapy, Intravenous therapy, HCT, Pharmaceutical industry

ROCKVILLE, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today reported financial results for the full-year ended December 31, 2023, and provided a corporate update.

Key Points: 
  • The trial is expected to enroll 92 evaluable patients and remains on track to complete enrollment in H1 2024.
  • Other income for the year ended December 31, 2023 is primarily comprised of interest income of $1,439,000 and an exchange gain of $3,000.
  • Cash and cash equivalents totaled $23.2 million as of December 31, 2023, compared to $41.8 million as of December 31, 2022.
  • ET to discuss its financial results for the full-year ended December 31, 2023 and provide a corporate update.

Apprenticeship Programs to Forge New Paths in UAE Education Sector

Retrieved on: 
Monday, March 18, 2024
Employment, Growth, University, Learning, Apprenticeship, Private sector, Student, Curriculum, Future, Labour, Workforce, Higher, Inclusive, HCT, Nursing

ABU DHABI, UAE, March 18, 2024 /PRNewswire/ -- As global education trends evolve, there's a noticeable shift towards a more integrated approach, blending academic learning with practical, real-world experience. This trend, reflecting a universal move towards innovation, sees educational systems worldwide, including the UAE, adapting to the changing demands of the Job Market. According to European commission, Apprentices find jobs faster, retain them longer, and are better paid than other students. Here in the Middle East, as the UAE propels forward, it embraces innovative strategies to equip its youth with the skills necessary for tomorrow's challenges, ensuring that the nation remains at the forefront of educational excellence and economic advancement, ready to meet the demands of an ever-evolving global marketplace.

Key Points: 
  • This trend, reflecting a universal move towards innovation, sees educational systems worldwide, including the UAE, adapting to the changing demands of the Job Market.
  • According to European commission, Apprentices find jobs faster, retain them longer, and are better paid than other students .
  • The Higher Colleges of Technology (HCT), UAE's largest Federal Higher Education Institute, through its applied educational model transformation aptly named "Shaping the Future" is adopting apprenticeship-based programs to enhance its educational offerings.
  • The first 4-month apprenticeship period commenced in September 2023, with students registered to undertake the hands-on training as part of their education requirement.

Apprenticeship Programs to Forge New Paths in UAE Education Sector

Retrieved on: 
Monday, March 18, 2024
Employment, Growth, University, Learning, Apprenticeship, Private sector, Student, Curriculum, Future, Labour, Workforce, Higher, Inclusive, HCT, Nursing

ABU DHABI, UAE, March 18, 2024 /PRNewswire/ -- As global education trends evolve, there's a noticeable shift towards a more integrated approach, blending academic learning with practical, real-world experience. This trend, reflecting a universal move towards innovation, sees educational systems worldwide, including the UAE, adapting to the changing demands of the Job Market. According to European commission, Apprentices find jobs faster, retain them longer, and are better paid than other students. Here in the Middle East, as the UAE propels forward, it embraces innovative strategies to equip its youth with the skills necessary for tomorrow's challenges, ensuring that the nation remains at the forefront of educational excellence and economic advancement, ready to meet the demands of an ever-evolving global marketplace.

Key Points: 
  • This trend, reflecting a universal move towards innovation, sees educational systems worldwide, including the UAE, adapting to the changing demands of the Job Market.
  • According to European commission, Apprentices find jobs faster, retain them longer, and are better paid than other students .
  • The Higher Colleges of Technology (HCT), UAE's largest Federal Higher Education Institute, through its applied educational model transformation aptly named "Shaping the Future" is adopting apprenticeship-based programs to enhance its educational offerings.
  • The first 4-month apprenticeship period commenced in September 2023, with students registered to undertake the hands-on training as part of their education requirement.

NMDP Awards 25th Annual ‘Amy Scholars’ Grant, Furthering Post-Transplant Research

Retrieved on: 
Wednesday, March 6, 2024
Bone marrow, Senior, Doctor of Philosophy, HCT, Research, Hematology, Graft-versus-host disease, Physician, Partnership, Data, University, Risk assessment, NMDP, Nursing, Patient, Disease, McGinn, DRS, Health equity, Laboratory, Buchbinder, Wilfrid Sellars, Pharmaceutical industry

Cieri and Sacirbegovic in their research efforts to improve the lives of those battling blood cancers and blood disorders.

Key Points: 
  • Cieri and Sacirbegovic in their research efforts to improve the lives of those battling blood cancers and blood disorders.
  • We are especially grateful to the Moore family, who generously funded the Amy Scholars Research Program in 2024,” said Joy King, Chief Advancement Officer, NMDP, and Executive Director, NMDP.
  • Since 1998, NMDP has invested more than $12 million, funding 51 early-career investigators and helping them develop research portfolios and establish their laboratories.
  • “For years, we have supported groundbreaking research by collaborating with an extensive network of physicians and scientists in impacting outcomes.

Aduro Clean Technologies Welcomes a Global Multinational Food Packaging Company into its Customer Engagement Program

Retrieved on: 
Tuesday, March 5, 2024
ACT, Extended producer responsibility, Chemistry, HCT, Food packaging, Growth, Municipal solid waste, Nature, ESG, Food, Plastic, Oil, CEP, Recycling, Food industry, Waste management, EPR

(“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is excited to announce the onboarding of a leading, global multinational food packaging company (“MFP Company” or the “Client”) to its Customer Engagement Program (CEP).

Key Points: 
  • (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is excited to announce the onboarding of a leading, global multinational food packaging company (“MFP Company” or the “Client”) to its Customer Engagement Program (CEP).
  • MFP Company is a prominent player in the global food processing and distribution sector, boasting an attractive portfolio of well-known brands.
  • At the core of its operations, MFP Company integrates environmental, social, and governance (ESG) principles, focusing on innovation and efficiency.
  • MFP Company advocates for a circular economy approach to address packaging pollution, innovating in sustainable packaging design, and advocating for the reuse and recycling of materials.

TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR

Retrieved on: 
Monday, February 26, 2024
AML, ALL, Chimera, Syndrome, HCT, Quality of life, Safety, Society, MDS, Therapy, Immunosuppression, Patient, Acute leukemia, MRD, TCR, Transplant, Acute myeloid leukemia, KOL, DNA, Cancer, Medical device

“We are excited to report updated data from our heme program, with eight patients across our treatment arms and six patients in our control arm.

Key Points: 
  • “We are excited to report updated data from our heme program, with eight patients across our treatment arms and six patients in our control arm.
  • We remain encouraged to see that no relapses have occurred to date in treated patients, four of whom have been on the study for over ten months.
  • Unfortunately, roughly 40% of patients relapse following HCT, at which point there are limited treatment options and a poor prognosis.
  • A replay will be made available on the “ Events and Presentations ” section of the Company’s investor relations website at ir.tscan.com .

NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial

Retrieved on: 
Tuesday, February 20, 2024
Haematopoietic system, Incidence, Bone marrow, Senior, Infection, Toxicity, MMUD, HCT, Malignancy, Graft-versus-host disease, Quality of life, ACCESS, GVHD, Safety, NMDP, Health, Patient, OHSU, Survival, Clinical trial, Health equity, Research, Vaccine

The trial is sponsored by NMDP through the Center for International Blood and Marrow Transplant Research (CIBMTR®).

Key Points: 
  • The trial is sponsored by NMDP through the Center for International Blood and Marrow Transplant Research (CIBMTR®).
  • The OPTIMIZE trial hypothesizes that a reduced PTCy dosage could reduce these risks while still effectively guarding against GvHD.
  • The OPTIMIZE trial’s goals include:
    Improve patient survival and quality of life by decreasing acute and long-term toxicities associated with standard dose PTCy.
  • This trial recently completed enrollment in its adult arms ahead of schedule and is continuing to enroll within its pediatric arm.

CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings

Retrieved on: 
Wednesday, February 21, 2024
Technology, Health, General Health, Public Relations, Investor Relations, Communications, Health Technology, Medical Devices, Genetics, Internet, Mobile, Wireless, Clinical Trials, Hematopoietic stem cell transplantation, Caregiver, Patient, AML, Digital Solutions, ALL, HLA, Chimera, HCT, High, Medicine, Transplant, Prognosis, Cell, HA2, Nucleic acid thermodynamics, MDS, University, Antigen, HA1, Accuracy and precision, Medical device

“Cellular transplant centers are recognizing the value of our digital and patient monitoring solutions, and we look forward to sharing our latest advancements as we work to expand our presence in this dynamic ecosystem,” said Kashif Rathore, Chief of Patient and Digital Solutions at CareDx.

Key Points: 
  • “Cellular transplant centers are recognizing the value of our digital and patient monitoring solutions, and we look forward to sharing our latest advancements as we work to expand our presence in this dynamic ecosystem,” said Kashif Rathore, Chief of Patient and Digital Solutions at CareDx.
  • CareDx will be showcasing its broad portfolio of digital health solutions that address needs in the cellular transplant and therapy ecosystem including workflow management, regulatory reporting, medication management, and remote patient monitoring.
  • Product solution areas include:
    Ottr® Cellular: Designed as a workflow management solution for hematopoietic cellular transplant and cellular therapy centers.
  • Poster 299: Analytical Validation of AlloCell cfDNA - a Highly Sensitive, Precise, and Accurate Cell-Free DNA-Based Test for Allogeneic Cell Therapy Monitoring.